Second-generation CK2α inhibitors targeting the αD pocket. Issue 11 (27th February 2018)

• Record Type: Journal Article
• Authors: Iegre, Jessica; Brear, Paul; De Fusco, Claudia; Yoshida, Masao; Mitchell, Sophie L.; Rossmann, Maxim; Carro, Laura; Sore, Hannah F.; Hyvönen, Marko; Spring, David R.
• Is Part Of: Chemical science. Volume 9:Issue 11(2018)
• Page Start: 3041
• Page End: 3049
• Publication Date: 2018-02-27
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c7sc05122k
• Languages: English
• ISSNs: 2041-6520

Abstract

Abstract : We describe the development of aCAM4712, a novel CK2α inhibitor which does not interact with the ATP binding site and shows improved properties over the first-generation inhibitorCAM4066 . Abstract : CK2 is a critical cell cycle regulator that also promotes various anti-apoptotic mechanisms. Development of ATP-non-competitive inhibitors of CK2 is a very attractive strategy considering that the ATP binding site is highly conserved among other kinases. We have previously utilised a pocket outside the active site to develop a novel CK2 inhibitor, CAM4066 . WhilstCAM4066 bound to this new pocket it was also interacting with the ATP site: herein, we describe an example of a CK2α inhibitor that binds completely outside the active site. This second generation αD-site binding inhibitor, compoundCAM4712 (IC50 = 7 μM, GI50 = 10.0 ± 3.6 μM), has numerous advantages over the previously reportedCAM4066, including a reduction in the number of rotatable bonds, the absence of amide groups susceptible to the action of proteases and improved cellular permeability. Unlike withCAM4066, there was no need to facilitate cellular uptake by making a prodrug. Moreover, CAM4712 displayed no drop off between its ability to inhibit the kinase in vitro (IC50 ) and the ability to inhibit cell proliferation (GI50 ).